266 filings
Page 11 of 14
8-K
kg3puf5p5myqge3
3 Dec 19
Eton Pharmaceuticals Announces Commercial Availability of Biorphen® (phenylephrine HCI) Injection
7:39am
S-3
487ti 652r3g37g9
2 Dec 19
Shelf registration
5:04pm
8-K
iaxzvk5l8x 1t3l
14 Nov 19
Eton Pharmaceuticals Announces Third Quarter Financial Results and Highlights Business Progress
12:00am
8-K
hvx2zt0zpz4m0 smg3mr
22 Oct 19
Eton Pharmaceuticals Announces U.S. FDA Approval of Biorphen® (phenylephrine HCI) Injection
7:33am
8-K
px0v8iz1z1xdzmz8q06
19 Aug 19
Eton Pharmaceuticals Announces Positive Results from Clinical Study Report of ET-104
7:28am
4
1bag 6msf
13 Aug 19
Eton Pharmaceuticals / SEAN BRYNJELSEN ownership change
4:04pm
4
cdevd dd4xiyv
12 Aug 19
Eton Pharmaceuticals / CHARLES J CASAMENTO ownership change
4:17pm
8-K
5b1ofeiyyowc bke
6 Aug 19
Eton Announces Second Quarter Financial Results and Highlights Business Progress
4:20pm
8-K
vfm02 dg71vs8m
1 Aug 19
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-105
8:21am
8-K
52h4nud24o0a5q
12 Jul 19
Eton Pharmaceuticals Provides Update on EM-100 Program
4:48pm
8-K
4vx etrtd0p3u2e25
13 Jun 19
Eton Pharmaceuticals Announces Licensing of Lamotrigine New Drug Application and Provides Pipeline Update
4:12pm
8-K
4sj42
12 Jun 19
Submission of Matters to a Vote of Security Holders
5:28pm
SC 13G
oaawav qapqe
24 May 19
Eton Pharmaceuticals, Inc.
5:20pm
4
j4ruicr4558k98
22 May 19
Eton Pharmaceuticals / SEAN BRYNJELSEN ownership change
4:25pm
8-K
87quppn6lx
7 May 19
Eton Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Business Progress
4:12pm
DEFA14A
vyesr
26 Apr 19
Additional proxy soliciting materials
4:36pm
DEF 14A
mow8j sklo4
26 Apr 19
Definitive proxy
4:34pm